QOPEVSDrugPatentWatch

QOPE vs DrugPatentWatch for drug patent and generic entry questions

DrugPatentWatch is a pharmaceutical patent intelligence service with U.S. and international patent data. QOPE covers U.S. drug patents and exclusivity from the FDA Orange Book and Purple Book, and connects them to shortages, prices, makers and Medicare prescribing.

Information as of October 7, 2026Start 14-day trialSee pricing
Side by side

Where the two overlap

Drug patents, exclusivity and generic entry. Facts about DrugPatentWatch come from its own website, with a source link on each row.

What it is
QOPEA self-serve platform that turns public U.S. healthcare data into ranked answers, drug and provider profiles, lead lists and watch lists.
DrugPatentWatchDescribes itself as pharmaceutical patent intelligence since 2002.Source
Built for
QOPEGeneric and biosimilar makers, investors, consultants, procurement and commercial teams working on U.S. drugs.
DrugPatentWatchLists pharmaceutical companies, investors, consultants, attorneys and researchers.Source
Patent data
QOPEU.S. patents and exclusivity from the FDA Orange Book, biologic exclusivity from the Purple Book, and staged generics that have passed FDA review and wait on patents or exclusivity.
DrugPatentWatchU.S. and international patents in 134 countries, Paragraph IV challenges, authorized generics, and litigation including the Patent Trial and Appeal Board.Source
Other drug data
QOPEFDA shortages and recalls, NADAC prices, Medicaid Drug Rebate Program data, Medicare Part B and Part D spend and prescribers, NDC listings and FDA labels.
DrugPatentWatchDrug candidates in clinical trials, U.S. drug prices, U.S. top drug sales and ingredient suppliers.Source
Main tools
QOPEDrug Profile, Patent Cliff, Shortages Tracker, Radar alerts and free public drug pages.
DrugPatentWatchSearch, dashboards, custom email alerts, data export and the Deep Research Engine, an AI research assistant.Source 1Source 2
Getting access
QOPESelf-serve sign-up with a 14-day trial. No sales call needed.
DrugPatentWatchSelf-serve subscription. Enterprise plans by contact.Source
Pricing
QOPEPublished prices: Regular $450, Pro $1,250, Teams $4,750 per month, with lower annual prices.
DrugPatentWatchStarter USD 1,000/month or USD 8,000/year. Professional USD 3,000/month or USD 24,000/year. Enterprise priced on request.Source
What you can do on QOPE

Four views for patent and generic entry work

Each one is a prepared view, so you start from an answer instead of an empty table.

01 / PATENT CLIFF

See which brands lose protection next

Brands whose last Orange Book patent or exclusivity is ending, with Part D spend, how crowded generic entry already is, a market-open calendar and the prescribers who write the most for each expiring brand.

How the patent cliff works
Drug, manufacturer and date timelines with one highlighted change raising a single alert
02 / DRUG PROFILE

One page per drug

Patents and exclusivity, generic and biosimilar makers, NADAC price, shortages, recalls, top Part D prescribers and Part B spend for each drug, with an Excel export.

How the drug profile works
Drug profile for apixaban with KPI strip, patent and exclusivity timeline, price trend and Excel export
03 / SHORTAGES TRACKER

See where supply is thin

Current FDA drug shortages with supplier depth from the Orange Book, market exits from the Medicaid Drug Rebate Program file and a manufacturer reliability scorecard.

How the shortages tracker works
Drug tracking sheet with stock levels; the lowest-stock drug is flagged
04 / PUBLIC DRUG PAGES

Free pages anyone can open

Patent and exclusivity dates, generic makers, shortage status and NADAC price for widely used drugs, open to everyone without an account.

Browse drug pages
Three open-access drug reference cards beside an unlocked padlock
Which one fits

Pick by the question you need answered

Both are useful. They answer different questions.

QOPE may fit better when
  • You need U.S. patent and exclusivity dates next to shortages, prices and Medicare prescribing.
  • You want to see which prescribers write the most for a brand that is losing protection.
  • You want alerts when a first generic launches or a shortage starts.
  • You want free public drug pages anyone on your team can open.
DrugPatentWatch may fit better when
  • You need patents outside the United States.
  • You need Paragraph IV challenges or patent litigation records.
  • You need drug sales figures or ingredient supplier lists.
Questions

Common questions

Where do QOPE patent dates come from?

From the FDA Orange Book for small-molecule drugs and the FDA Purple Book for biologics. QOPE covers U.S. protection only.

Does QOPE show who prescribes a drug that is losing protection?

Yes. The patent cliff ranks prescribers by Medicare Part D spend on expiring brands, filtered by state and specialty.

Can I look up a drug without an account?

Yes. Public drug pages show patent and exclusivity dates, generic makers, shortage status and NADAC price without signing in.

How much does QOPE cost?

Published prices: Regular $450, Pro $1,250, Teams $4,750 per month, with lower annual prices.

Try it on your own question

Search a drug, a provider or a market today.

Regular$450/mo
Pro$1,250/mo
Teams$4,750/mo
One search across databases, documents, facilities and drugs